In the news...

NucleusHealth™ Receives FDA 510(k) Clearance for Nucleus.io™

San Diego, California (PRWEB) May 24, 2017 — NucleusHealth™, advancing clinical practice and patient care through innovative medical image management and interpretation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Nucleus.io technology.

 

Nucleus.io is a web-based, scalable and secure cloud platform for medical image management. At the core is patented streaming technology that provides diagnostic workstation performance in a web browser. Nucleus.io can improve collaboration and patient care via fast access to images, reduce IT overhead, is optimized for machine learning, and provides flexibility and customization through numerous RESTful APIs. “We’re excited to bring our latest advance to today’s increasingly complex and demanding medical image management environment, where real-time provider access to medical images is critical,” said Claude Hooton, NucleusHealth President and Chief Operating Officer. “Nucleus.io redefines the entire imaging ecosystem and improves medical image workflow in a highly secure, accessible and reliable fashion – from ingesting, delivering, and viewing medical images to interpretation and storage.”

READ FULL PRESS RELEASE